News & Updates

COVID-19 causes lighter heart damage during second vs first wave of infections
COVID-19 causes lighter heart damage during second vs first wave of infections
20 Dec 2021

In fatal cases of the coronavirus disease 2019 (COVID-19), cardiac inflammation, cardiomyocyte injury, and microvascular thrombogenicity are substantially lower in the second vs first wave of infections, a new study has found.

COVID-19 causes lighter heart damage during second vs first wave of infections
20 Dec 2021
Ambulatory better than central BP at predicting death, cardiovascular events in dialysis patients
Ambulatory better than central BP at predicting death, cardiovascular events in dialysis patients
18 Dec 2021
Apixaban outdoes rivaroxaban at preventing VTE, bleeding in adults
Apixaban outdoes rivaroxaban at preventing VTE, bleeding in adults
17 Dec 2021

Patients with venous thromboembolism (VTE) who are new users of apixaban are less likely to experience recurrent VTE and bleeding than new users of rivaroxaban, a study has shown.

Apixaban outdoes rivaroxaban at preventing VTE, bleeding in adults
17 Dec 2021
Hypertension with proteinuria ups risk of AF, cardiovascular events
Hypertension with proteinuria ups risk of AF, cardiovascular events
16 Dec 2021 byStephen Padilla

Hypertension and proteinuria contribute to an increased risk of atrial fibrillation (AF) as well as stroke, heart failure admission, and cardiovascular death in older adults, and such risk is greater when both conditions are present, according to a study.

Hypertension with proteinuria ups risk of AF, cardiovascular events
16 Dec 2021